These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 14767338)

  • 1. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis.
    Marengo SR; Chen DH; Evan AP; Sommer AJ; Stowe NT; Ferguson DG; Resnick MI; MacLennan GT
    Urol Res; 2006 Jun; 34(3):200-10. PubMed ID: 16479391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR; Glenton PA; Byer KJ
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
    Moriyama MT; Glenton PA; Khan SR
    J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection.
    Worcester E; Evan A; Bledsoe S; Lyon M; Chuang M; Orvieto M; Gerber G; Coe F
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1061-9. PubMed ID: 17028259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.
    Thamilselvan S; Khan SR
    J Nephrol; 1998; 11 Suppl 1():66-9. PubMed ID: 9604816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS; Ma MC; Chen J; Chen CF
    Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts.
    Umekawa T; Iguchi M; Uemura H; Khan SR
    BJU Int; 2006 Sep; 98(3):656-60. PubMed ID: 16925768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis.
    Gambaro G; Valente ML; Zanetti E; Della Barbera M; Del Prete D; D'Angelo A; Trevisan A
    J Am Soc Nephrol; 2006 Aug; 17(8):2213-9. PubMed ID: 16790510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
    J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.